Pharmacokinetics and safety of oseltamivir in patients with end-stage renal disease treated with automated peritoneal dialysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics and safety of oseltamivir in patients with end-stage renal disease treated with automated peritoneal dialysis

Published:2015-03-23 Issue:4 Volume:79 Page:624-635
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Patel Kashyap¹,Rayner Craig R.²,Giraudon Mylène³,Kamal Mohamed A.⁴,Morcos Peter N.⁴,Robson Richard⁵,Kirkpatrick Carl M.¹

Affiliation:

1. Monash University; Melbourne Victoria Australia

2. d3 Medicine; Parsippany NJ USA

3. F. Hoffmann-La Roche Ltd; Basel Switzerland

4. Roche Translational Clinical Research Center Inc.; New York NY USA

5. Christchurch Clinical Studies Trust; Christchurch New Zealand

Funder

Roche

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12526/fullpdf

Reference23 articles.

1. Global trends in rates of peritoneal dialysis;Jain;J Am Soc Nephrol,2012

2. Advantages and disadvantages of automated peritoneal dialysis compared to continuous ambulatory peritoneal dialysis;Blake;Perit Dial Int,1999

3. Automated vs continuous ambulatory peritoneal dialysis: a systematic review of randomised controlled trials;Rabindranath;Nephrol Dial Transplant,2007

4. The impact of peritoneal permeability and residual renal function on PD prescription;Harty;Perit Dial Int,1996

5. European best practice guidelines for peritoneal dialysis. 6 Automated peritoneal dialysis;Dombros;Nephrol Dial Transplant,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and evaluation of oseltamivir phosphate dual-phase extended-release tablets for the treatment of influenza;International Journal of Pharmaceutics;2024-08

2. How to use COVID-19 antiviral drugs in patients with chronic kidney disease;Frontiers in Pharmacology;2023-02-09

3. Oseltamivir—Current Dosing Recommendations Reduce the Therapeutic Benefit in Patients With Mild to Moderate Renal Function and/or Large Body Mass: A Review of the Literature With Recommendations to Optimize Dosing, Including the Use of Therapeutic Drug Monitoring;Therapeutic Drug Monitoring;2021-02

4. Utilization of data below the analytical limit of quantitation in pharmacokinetic analysis and modeling: promoting interdisciplinary debate;Bioanalysis;2018-08-01

5. Solubility Determination of Active Pharmaceutical Ingredients Which Have Been Recently Added to the List of Essential Medicines in the Context of the Biopharmaceutics Classification System–Biowaiver;Journal of Pharmaceutical Sciences;2018-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3